BEND5 and colorectal carcinoma: Because prognosis is poor in earlier-stage CRC patients without metastasis exhibiting hypermethylation of the promoter region of BEND5 in their tumors (Figures 2 and 3), BEND5 hypermethylation may be a prognostic indicator that enables identifying high-risk patients for frequent monitoring.